Finance / Per-Study Forecast
Study Drill · Atopic Dermatitis
DERM-302 / revenue book
● 38 active subjects · 184 visits remaining
Recognized YTD
$148.4K
actual
Remaining Contract
$170.8K
under SOW
$ / Subject
$8,400
full course
Q4 Forecast
$319.2K
this quarter
Subject Revenue Waterfall
recognized · remainingTotal contract value · 38 subjects$319,200
Subjects · 38
| Subject | Visits | Recog. | Status |
|---|---|---|---|
| 1000 | 3/12 | $2,100 | Invoiced |
| 1001 | 4/12 | $2,800 | Invoiced |
| 1002 | 5/12 | $3,500 | Invoiced |
| 1003 | 6/12 | $4,200 | Pending |
| 1004 | 7/12 | $4,900 | Invoiced |
| 1005 | 7/12 | $4,900 | Hold |
| 1006 | 8/12 | $5,600 | Invoiced |
| 1007 | 3/12 | $2,100 | Invoiced |
| 1008 | 4/12 | $2,800 | Invoiced |
| 1009 | 5/12 | $3,500 | Invoiced |
| 1010 | 6/12 | $4,200 | Pending |
| 1011 | 7/12 | $4,900 | Invoiced |
| 1012 | 7/12 | $4,900 | Hold |
| 1013 | 8/12 | $5,600 | Invoiced |
| 1014 | 3/12 | $2,100 | Invoiced |
| 1015 | 4/12 | $2,800 | Invoiced |
| 1016 | 5/12 | $3,500 | Invoiced |
| 1017 | 6/12 | $4,200 | Pending |
| 1018 | 7/12 | $4,900 | Invoiced |
| 1019 | 7/12 | $4,900 | Hold |
| 1020 | 8/12 | $5,600 | Invoiced |
| 1021 | 3/12 | $2,100 | Invoiced |
| 1022 | 4/12 | $2,800 | Invoiced |
| 1023 | 5/12 | $3,500 | Invoiced |
| 1024 | 6/12 | $4,200 | Pending |
| 1025 | 7/12 | $4,900 | Invoiced |
| 1026 | 7/12 | $4,900 | Hold |
| 1027 | 8/12 | $5,600 | Invoiced |
| 1028 | 3/12 | $2,100 | Invoiced |
| 1029 | 4/12 | $2,800 | Invoiced |
| 1030 | 5/12 | $3,500 | Invoiced |
| 1031 | 6/12 | $4,200 | Pending |
| 1032 | 7/12 | $4,900 | Invoiced |
| 1033 | 7/12 | $4,900 | Hold |
| 1034 | 8/12 | $5,600 | Invoiced |
| 1035 | 3/12 | $2,100 | Invoiced |
| 1036 | 4/12 | $2,800 | Invoiced |
| 1037 | 5/12 | $3,500 | Invoiced |
Visit Schedule · next 12 weeks · billable revenue
AR Aging · this study
0-30 days$26,712
12 invoices
31-60 days$13,356
7 invoices
61-90 days$5,936
4 invoices
90+ days$2,968
1 invoices